Hénichart JP - Search Results

1

[Mutagenesis of the human histamine H1 receptor and design of new antihistamine agents].

Differding E, Gillard M, Moguilevsky N, Varsalona F, Noyer M, Daliers J, Goldstein S, Neuwels M, Lassoie MA, Guillaume JP, Bascour M, Bollen A, Hénichart JP. Differding E, et al. Among authors: henichart jp. J Pharm Belg. 1996 May-Jun;51(3):155-60. J Pharm Belg. 1996. PMID: 8778348 Review. French.

2

[Conformational analysis of peptide antagonists in the design of pseudopeptide and non-peptide antagonists].

Goldstein S, Neuwels M, Lassoie MA, Houssin R, Caumont K, Differding E, Henichart JP. Goldstein S, et al. Among authors: henichart jp. J Pharm Belg. 1995 Mar-Jun;50(2-3):213-22. J Pharm Belg. 1995. PMID: 7545749 French.

3

Pharmacological and functional characterisation of the wild-type and site-directed mutants of the human H1 histamine receptor stably expressed in CHO cells.

Moguilevsky N, Varsalona F, Guillaume JP, Noyer M, Gillard M, Daliers J, Henichart JP, Bollen A. Moguilevsky N, et al. Among authors: henichart jp. J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):91-102. doi: 10.3109/10799899509045210. J Recept Signal Transduct Res. 1995. PMID: 8903934

4

Discovery of orally bioavailable NK1 receptor antagonists.

Genicot C, Christophe B, Collart P, Gillard M, Goossens L, Hénichart JP, Lassoie MA, Moureau F, Neuwels M, Nicolas JM, Pasau P, Quéré L, Ryckmans T, Stiernet F, Taverne T, Van Keulen BJ. Genicot C, et al. Among authors: henichart jp. Bioorg Med Chem Lett. 2003 Feb 10;13(3):437-42. doi: 10.1016/s0960-894x(02)00956-3. Bioorg Med Chem Lett. 2003. PMID: 12565946

5

The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes.

Noyer M, Gillard M, Matagne A, Hénichart JP, Wülfert E. Noyer M, et al. Among authors: henichart jp. Eur J Pharmacol. 1995 Nov 14;286(2):137-46. doi: 10.1016/0014-2999(95)00436-o. Eur J Pharmacol. 1995. PMID: 8605950

6

Phosphodiesterase 4 inhibitors as airways smooth muscle relaxant agents: synthesis and biological activities of triazine derivatives.

Leroux F, van Keulen BJ, Daliers J, Pommery N, Hénichart JP. Leroux F, et al. Among authors: henichart jp. Bioorg Med Chem. 1999 Mar;7(3):509-16. doi: 10.1016/s0968-0896(98)00266-1. Bioorg Med Chem. 1999. PMID: 10220036

7

N-Aminoindoline derivatives as inhibitors of 5-lipoxygenase.

Audouin C, Mestdagh N, Lassoie MA, Houssin R, Hénichart JP. Audouin C, et al. Among authors: henichart jp. Bioorg Med Chem Lett. 2001 Mar 26;11(6):845-8. doi: 10.1016/s0960-894x(01)00077-4. Bioorg Med Chem Lett. 2001. PMID: 11277534

8

[Metabolic treatment of cancer].

Vamecq J, Mestdagh N, Henichart JP, Poupaert J. Vamecq J, et al. Among authors: henichart jp. J Pharm Belg. 1990 Nov-Dec;45(6):361-74. J Pharm Belg. 1990. PMID: 2086759 Review. French.

9

A flexible approach to the design of new potent substance P receptor ligands.

Millet R, Goossens L, Bertrand-Caumont K, Goossens JF, Houssin R, Hénichart JP. Millet R, et al. Among authors: henichart jp. J Pharm Pharmacol. 2001 Jul;53(7):929-34. doi: 10.1211/0022357011776324. J Pharm Pharmacol. 2001. PMID: 11480541

10

Conformation of the tripeptide Cbz-Pro-Leu-Trp-OBzl(CF3)2 deduced from two-dimensional 1H-NMR and conformational energy calculations is related to its affinity for NK1-receptor.

Millet R, Goossens L, Goossens JF, Chavatte P, Bertrand-Caumont K, Houssin R, Hénichart JP. Millet R, et al. Among authors: henichart jp. J Pept Sci. 2001 Jun;7(6):323-30. doi: 10.1002/psc.326. J Pept Sci. 2001. PMID: 11461046

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

174 results

Search Page

Filters